NCT05305261

Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.

Maternal to Neonatal Transmission Antibody Covid-19 Study - The TRAB CoV-19

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 197 (actual)
• Sponsor: National University of Malaysia · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

This is a prospective clinical study aiming to investigate on the transplacental antibody transmission post Covid-19 infection during pregnancy.

Detailed description

Covid -19 infection has been a significant public health burden as it shifted the paradigm of infectious diseases aiming to control the spread and enhance public immune protection. The introduction of Covid -19 vaccination in December 2020 aimed to combat the infection, thus tremendously helping to flatten the disease worldwide. Channeling the vaccine for the obstetrics field is one of the hallmark strategies to reduce maternal morbidity and mortality. The efficacy of vaccination for the pregnant lady has been established. However, fetus protection via transmission of the antibody during pregnancy is still uncertain. Therefore, this study aims to consolidate further evidence of transplacental antibody post-maternal vaccination aiming for fetal protection following delivery.

Conditions

• Antibody
• Vaccine
• Maternal
• Cord

Timeline

• Start date: 2021-07-29
• Primary completion: 2022-03-18
• Completion: 2022-03-18
• First posted: 2022-03-31
• Last updated: 2022-04-08

Locations

1 site across 1 country: Malaysia